The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Use of Male Condoms During and After Randomized, Controlled Trial Participation in Cameroon

May 16, 2005

The current study evaluated patterns of long-term use of male condoms among partners of 966 Cameroonian women who received instruction on condoms and STD testing and treatment in eight intensive, monthly counseling sessions. The researchers used an interrupted time-series design. Participants reported condom use and other covariates at enrollment in the study, then monthly for six months during the randomized, controlled trial, and at approximately 14 months after the trial.

Consistent condom use, the researchers found, began decreasing while the women were still receiving counseling. Every month in the trial was associated with an odds ratio of 0.96 (95 percent confidence interval [CI], 0.94-0.99) of consistent condom use and dropped substantively after the trial with a 0.39 (95 percent CI, 0.26-0.59) odds ratio in a logistic regression analysis. As each month passed, the incidence of unprotected sex increased by 3 percent (95 percent CI, 1-4 percent) with no statistically significant change during the condom use follow-up survey. Condom use in a coital act was 0.84 (95 percent CI, 0.78-0.92) less likely during the follow-up survey than during the trial.

"Only a few women sustained consistent condom use throughout the study period and for more than one year after," the investigators concluded. "It is important to continue documenting the impact of condom promotion in a rigorous manner and to identify content and delivery of counseling that will lead to sustained condom use beyond the intervention period."

Back to other news for May 16, 2005

Adapted from:
Sexually Transmitted Diseases
05.05.05; Vol. 32; No. 5: P. 300-307; Emelita L. Wong, Dr.P.H.; Ronald E. Roddy, M.P.H.; Heidi Tucker, M.P.H.; Ubald Tamoufe, M.Sc.; Kelley Ryan, B.A.; Falimatou Ngampoua, B.A.

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More HIV News
Find out how a Walgreens specially trained pharmacist can help you